The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.
GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...
In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...
SGLT2 diabetes meds like Jardiance or Farxiga do the same ... Both are risk factors for heart attack and stroke. “Another ...